Study at a glance
What was studied?
Four investigations examined skin samples, healthy volunteers, women given a hormone to test their kidney response, kidney tissue and mouse cells. They asked how age relates to vitamin D production, activation and breakdown.
What did the studies find?
In a small tested subset, older surgical skin samples produced less of an early vitamin D compound. A later small study of healthy volunteers did not detect a clear younger: older difference in the amount of skin precursor or the blood vitamin D3 response. The precursor is a starting substance used to make vitamin D3. Kidney function affected the interpretation of blood responses. A newer tissue and cell study found changes in proteins involved in vitamin D breakdown.
What does this mean?
The findings do not show one unavoidable pattern in every older person. More breakdown enzyme does not prove faster removal of vitamin D from human blood. Clearance means removal from the circulation.
What are the limits?
Studies were small or used selected tissue and experimental models. The human kidney biopsies came from people with kidney disease. Two historical clearance reports were available only as abstracts and were not counted among the four fully assessed investigations. These findings do not establish a personal supplement dose.
Read the full article below ↓Age-related differences in vitamin D handling depend on what is measured and who is studied. Skin precursor content, a blood response to hormonal stimulation and the amount of a kidney enzyme are different observations. This review compares four investigations of production, activation-related responses and breakdown mechanisms. They do not establish one inevitable metabolic decline or a universal direction of change in human vitamin D clearance. For the shorter account, read Age-Related Changes in Vitamin D Metabolism, Activation and Clearance: Study Summary.
Production, activation and clearance answer different questions
Vitamin D3 can be formed in skin after ultraviolet exposure. It is converted into other compounds, including circulating 25-hydroxyvitamin D and the active hormone calcitriol. The supply of a starting compound, the response of an activating pathway and the removal of a metabolite are therefore separate parts of vitamin D handling. An observation at one step does not establish what happens at every other step.
Clearance describes removal from the circulation. It is not simply another name for a low blood concentration. A concentration reflects both entry and removal, alongside distribution and other physiological influences. A smaller rise in calcitriol after stimulation could involve less production, greater removal or a combination. Without measurements that distinguish these processes, the concentration alone cannot identify the cause.
The same distinction applies within tissues. The amount of an enzyme can suggest a capacity for a reaction, but does not measure the amount of material passing through that reaction over time. This passage is called metabolic flux. Local responses also need not match the blood response; Tissue-Specific Vitamin D Metabolism and Gene Responses: Full Study examines that separate level of interpretation.
Chronological age can accompany changes in health, kidney function and study eligibility. It is therefore important to distinguish an age-associated result from an effect caused by ageing itself. The broader physiological setting is introduced in Vitamin D and Age-Related Decline. The studies below show why a single age label is insufficient to explain every metabolic finding.
Historical skin experiments: a reduced precursor in selected tissue
MacLaughlin and Holick examined skin obtained during surgery from 28 people aged 8 to 92. The study measured 7-dehydrocholesterol, the skin precursor from which vitamin D3 can be formed. It found lower precursor concentrations in the epidermis, the outer skin layer, with increasing age. Concentrations in the deeper dermal layer were relatively stable.
The tissue came from different anatomical sites and operations, including breast surgery and amputation. The ultraviolet-exposure experiment involved a small representative subset, rather than 28 separate irradiation comparisons. Older specimens produced less previtamin D3 under the experimental conditions. Both younger and older specimens retained the ability to produce it.
These findings support an age-associated difference in this selected tissue collection. They do not measure the vitamin D response of an intact older person going outdoors. They also do not measure kidney activation or clearance from blood. Children were included among the younger samples, and anatomical location, underlying health and tissue handling complicate a simple young-adult versus older-adult interpretation.
The result remains useful historical evidence about skin biology. Its limit is the breadth of the conclusion it can support. A reduction observed in selected surgical specimens cannot establish that every older adult has the same reduction in skin production, nor define a safe or effective sunlight exposure for an individual.
Healthy volunteers give an important qualification
Borecka and colleagues studied 11 younger and 10 older healthy volunteers in a standardised winter experiment. Their mean ages were approximately 30 and 70 years. Participants were ambulant White adults with a restricted range of skin types. The researchers used matched buttock biopsies and a single simulated-sunlight exposure, then measured skin precursor and blood responses with modern analytical methods.
They did not detect a lower starting skin precursor concentration in the older group. The measured serum vitamin D3 response also did not show a statistically clear age-by-time difference. This is important contrary evidence against treating lower skin production as an unavoidable consequence of age.
However, failure to detect a difference is not proof that the groups are equivalent. The sample was small, and smaller differences could have been missed. A statistically clear within-group rise in younger participants, alongside a less statistically clear rise in older participants, is not itself a test demonstrating that their responses differ. The comparison between groups must answer that question.
The two skin studies also used different material and measurements. Borecka used matched biopsies from healthy volunteers and expressed precursor relative to protein. The older study used heterogeneous surgical specimens and separated skin layers, with different ways of expressing the results. These differences make a single combined estimate inappropriate. The later findings qualify the historical account without proving that the earlier tissue observations were false.
Healthy mobile volunteers cannot represent all frail or institutionalised older people. Nor does one experimental exposure describe habitual vitamin D supply over a year. The defensible conclusion is that preserved skin precursor and a measurable vitamin D3 response are possible in selected healthy older adults. These experiments do not establish an individual supplement requirement.
Kidney response: separating age from renal function
Tsai and colleagues studied four groups of women: 10 premenopausal women, eight postmenopausal women, 10 older controls and eight older women with a previous hip fracture. Mean ages were approximately 37, 61, 78 and 78 years. The investigators measured the calcitriol response to parathyroid-hormone stimulation and estimated kidney function using creatinine clearance. This was a controlled physiological challenge in selected groups, not a longitudinal study following the same women as they aged.
The older groups had lower starting calcitriol and smaller stimulated increases. The women with a previous hip fracture had a smaller response than older controls. Yet circulating 25-hydroxyvitamin D did not decrease with age in this sample. The different vitamin D measurements therefore did not tell an identical story.
Kidney function substantially changed the interpretation. The response was related both to age and to renal function, but the age relationship disappeared when renal function was held constant statistically. A relationship with renal function remained marginally evident after adjustment for age. These findings do not cleanly isolate a direct effect of chronological age on the activating enzyme.
The study measured blood concentrations and their response, not renal enzyme activity or a directly measured production rate. It also did not measure tracer clearance. The authors acknowledged that increased removal could not be excluded as a contributor to lower concentrations. Describing the result simply as reduced activation would therefore be stronger than the measurements justify.
The hip-fracture comparison is relevant to skeletal physiology, but it does not show that the measured response caused a fracture or that a particular treatment would prevent one. Vitamin D and Bone supplies the broader skeletal context. Small samples, selection of women, older assays and differences in kidney function limit generalisation from this challenge experiment.
A newer investigation of the breakdown machinery
Zhang and colleagues examined the vitamin D-inactivating enzyme CYP24A1, also called 24-hydroxylase. Their programme combined public kidney datasets, tissue from mice of different ages, selected human kidney biopsies and experiments in mouse renal tubular cells. It adds evidence about catabolic machinery, meaning the processes involved in breaking down vitamin D metabolites. It is one investigation with several components, not several independent human studies.
The experimental mice were studied at 6, 12 and 18 months. The clinical biopsy comparison included only 10 patients with minimal change disease, a kidney disorder: five in each group. The reported mean ages were about 19 and 61 years, and nine of the 10 patients were male. These were not healthy older volunteers, and the older group’s mean does not establish that every participant was aged 65 or over.
Older mouse tissue showed more CYP24A1 protein or staining and less vitamin D receptor signal. A similar pattern was reported in the selected human biopsies. No clear difference was detected in the abundance of the activating enzyme CYP27B1. The public-dataset findings were mixed: not every age comparison or continuous-age association was statistically clear. The human transcript results should not be presented as definitive confirmation in healthy ageing kidneys.
In mouse tubular cells, changing Cyp24a1 expression altered receptor and transporter measurements. The transporters concerned phosphate and glucose handling. Providing calcitriol partly reversed selected changes under the tested conditions. These experiments help investigate a possible local pathway, but calcitriol exposure in cultured cells is not an oral vitamin D3 trial in older people.
The programme has substantial limitations. Some cell experiments modelled injury or senescence rather than natural ageing. The small clinical biopsy groups could differ in disease features and fibrosis as well as age. Several reported table labels, ages and correlation descriptions were inconsistent. This review therefore uses the cautious qualitative tissue and cellular findings, rather than disputed numerical details or a claim that every analysis confirmed the mechanism.
The publication was supplied as an accepted, unedited article in press. Its status and reporting limitations reduce the confidence appropriate to a strong mechanistic conclusion. They do not remove its usefulness as exploratory evidence about age-associated changes in vitamin D catabolism-related proteins.
More enzyme does not prove faster clearance
Zhang’s programme did not measure circulating or tissue vitamin D metabolite concentrations, substrate turnover, enzyme activity or tracer clearance. More CYP24A1 protein is therefore a mechanistic clue, not a measurement showing that vitamin D metabolites leave the blood more quickly. Equally, an unchanged amount of CYP27B1 cannot establish unchanged activation flux.
There are several unmeasured steps between the observations and a whole-body conclusion. The protein must be active under the relevant conditions, have access to its substrate and change the rate of metabolism sufficiently to affect the circulation. The relative contributions of different tissues also matter. The reported protein and cell-response results do not quantify those steps in older humans.
This distinction is especially important when interpreting a blood result. Low circulating 25-hydroxyvitamin D cannot, by itself, identify accelerated breakdown. Nor can a normal concentration establish that all local responses are normal. Functional Vitamin D Status introduces the distinction between a circulating measurement and physiological function.
Direct historical human kinetic reports would provide a different kind of evidence, but their access limits must be visible. Halloran and colleagues’ 1990 abstract reports similar calcitriol production and clearance in selected healthy younger and older men with preserved kidney function. Eastell and colleagues’ 1991 abstract reports a different age-related pattern in women, including decreased clearance in a kinetic subset. Only their abstracts were assessed here; neither is counted among the four fully assessed investigations.
Their full selection procedures, methods, tables and uncertainty could not be examined. The reports cannot be reconciled by assuming that sex, kidney function or protocol explains the difference. Nor should the word similar be turned into proof of equivalence. They are retained as limited historical qualifications, rather than hidden because they complicate a simple decline narrative. This review does not establish whether human clearance generally increases, decreases or remains unchanged with age.
What the evidence actually measures
| Investigation | What was measured | What was not established |
|---|---|---|
| MacLaughlin and Holick, 1985 | Selected surgical skin; precursor and ultraviolet-induced photoproduct | An intact-person response, renal activation or blood clearance |
| Tsai and colleagues, 1984 | Selected women; stimulated blood calcitriol and kidney function | A production rate, tracer clearance or age effect independent of renal function |
| Borecka and colleagues, 2024 | Healthy volunteers; matched skin precursor and single-exposure blood response | Formal equivalence or a result applying to all frail older people |
| Zhang and colleagues, 2026 | Datasets, mice, diseased human biopsies and mouse cells; protein and response measures | Metabolic flux, faster human clearance or oral D3 treatment benefit |
| Halloran, 1990; Eastell, 1991 · abstracts only | Reported historical human kinetic findings | A fully assessed comparison of methods or a universal clearance direction |
These distinctions prevent measurements from being substituted for one another. A skin precursor result concerns supply at the beginning of a pathway. A stimulated calcitriol concentration combines processes affecting that concentration. Kidney protein abundance concerns local machinery. None becomes a measured human clearance rate merely because all involve vitamin D.
The four programmes are distinct investigations; no participant overlap was identified between them. Different assays or datasets within one programme are not additional independent confirmations. The historical skin work, selected women’s physiological challenge, healthy-volunteer study and newer tissue/cell experiments also have different strengths. Counting favourable results would give a misleading impression of agreement.
Implications for interpreting ageing physiology
The evidence supports a context-dependent account of vitamin D handling. Some selected skin specimens and renal-response experiments show age-associated differences. Healthy-volunteer findings qualify inevitable skin decline, and kidney-function adjustment qualifies a direct age explanation for the stimulated response. Experimental catabolic-enzyme changes offer a possible local mechanism without establishing a whole-body clearance effect.
Metabolic observations should also be kept separate from clinical outcomes. None of these four investigations tests whether correcting a proposed clearance change improves muscle performance. Vitamin D and Muscle Function addresses that different physiological territory. A biochemical mechanism cannot substitute for an intervention demonstrating a functional benefit.
For the same reason, a blood test should be interpreted according to the compound measured, the population and the analytical context. Circulating Vitamin D Measurements: Physiological and Analytical Limitations: Full Study examines those limitations. The older-adult interpretation question is developed separately in Interpreting Vitamin D Status in Older Adults: Full Evidence Review.
Limits of this review
This is a selected narrative comparison, not an exhaustive systematic review or a pooled estimate. Full principal text and relevant methods, tables and figure descriptions were assessed for the four included investigations. The newer kidney paper’s main and supplementary figures were also visually examined. Claims requiring uninspected graph-only values in the other papers, or disputed extracted table values, were excluded. Halloran and Eastell remain abstract-only sources with unassessed full methods.
The central unresolved issue is the translation from local mechanisms and blood responses to human clearance rates. Uncertainty here is not proof that age has no effect. It means these assessed measurements cannot support one general direction or magnitude. They also cannot define a personal vitamin D dose, a universal blood target or a treatment to reverse ageing.
Sources
Related reading
Comparative Study of Healthy Older and Younger Adults Shows They Have the Same Skin Concentration of Vitamin D3 Precursor, 7-Dehydrocholesterol, and Similar Response to UVR
Vitamin D3 synthesis in human skin is initiated by solar ultraviolet radiation (UVR) exposure of precursor 7-dehydrocholesterol (7DHC), but influence of age on the early stage of vitamin D3 metabolism is uncertain.
Original paper ↗Read more →Revisiting the Sarcopenic Index in Older Adults with Reduced Kidney Function: Association with EWGSOP2-Defined Probable Sarcopenia
Similar patterns were observed in participants with reduced kidney function.
Original paper ↗Read more →Age-Related Changes in Vitamin D Metabolism, Activation and Clearance: Study Summary
A plain-English summary of vitamin D production and breakdown with age, explaining why enzyme changes do not prove faster removal from human blood.
Read more →Magnesium in Kidney Function and Disease: Implications for Aging and Sex: A Narrative Review
The objective of this work is to compile the available evidence regarding the role that Mg plays in health and disease, with a special focus on the elderly population with chronic kidney disease (CKD) and the eventual sex differences.
Original paper ↗Read more →Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults
Imbalances of blood biomarkers are associated with disease, and biomarkers may also vary non-pathologically across population groups.
Original paper ↗Read more →The age-related changes of dietary phosphate responsiveness in plasma 1,25-dihydroxyvitamin D levels and renal Cyp27b1 and Cyp24a1 gene expression is associated with renal α-Klotho gene expression in mice
We found that 1,25-dihydroxyvitamin D levels in plasma were significantly lower in the high phosphate group than the low phosphate group for 1 and 2 month-old mice, but not 13 month-old mice.
Original paper ↗Read more →Altered molecular repertoire of immune system by renal dysfunction in the elderly: is prediction and targeted prevention in the horizon?
Here, we investigated the relationship between serum 25-hydroxyvitamin D (25(OH)D) level and T cell differentiation in chronic HD patients.
Original paper ↗Read more →Assessment of Serum 25-Hydroxyvitamin D and Its Association in Type 2 Diabetes Mellitus Elderly Patients with Kidney Disease: A Retrospective Cross Sectional Study
The overall aim of this study is to determine the prevalence of vitamin D deficiency and its association with diabetic nephropathy in elderly patients with type 2 diabetes mellitus.
Original paper ↗Read more →Association between serum 25-hydroxyvitamin D levels and pulmonary function in elderly patients with chronic kidney disease: correlation analysis and exploratory predictive modelling
Diffusing capacity for carbon monoxide percent predicted (DLCO%) and diffusion impairment grade were also evaluated.
Original paper ↗Read more →Cooking methods are associated with inflammatory factors, renal function, and other hormones and nutritional biomarkers in older adults
Our aim was to evaluate the association of cooking methods with inflammatory markers, renal function, and other hormones and nutritional biomarkers in a general population of older adults.
Original paper ↗Read more →Frailty phenotype and multi-domain impairments in older patients with chronic kidney disease
We evaluated if Frailty Phenotype (FP) could identify older CKD-patients that may benefit the most from a CGA.
Original paper ↗Read more →Malnutrition in Elderly Patients with Chronic Kidney Disease: The Role of Albuminuria
As the presence of malnutrition in elderly CKD patients can pose serious health problems, the aim of our study was to identify, using different assessment tools, the relationship between nutrition with kidney function and albuminuria in elderly patients.
Original paper ↗Read more →Mental Health and Kidneys: The Interplay Between Cognitive Decline, Depression, and Kidney Dysfunction in Hospitalized Older Adults
This study aimed to investigate the associations among cognitive impairment, depression, and kidney involvement in elderly patients.
Original paper ↗Read more →Relationship between Serum Vitamin D and Leg Strength in Older Adults with Pre-Dialysis Chronic Kidney Disease: A Preliminary Study
This study aimed to investigate the relationship between a serum active vitamin D level and lower extremity muscle strength in elderly patients with pre-dialysis chronic kidney disease (CKD).
Original paper ↗Read more →Serum Copper-to-Zinc Ratio and Oxidative Stress Are Associated with Anemia in Older Adults with Cardiovascular-Kidney-Metabolic Syndrome
We analyzed 2391 NHANES 2011 to 2016 participants ≥ 50 years of age with CKM stage I-IV.
Original paper ↗Read more →Interaction Effect of Phase Angle and Age on Femoral Neck Bone Mineral Density in Patients with Non-Dialysis Chronic Kidney Disease Stage 5
Here, we investigated the association between phase angle (PhA) and bone mineral density (BMD) in dialysis-naïve patients with CKD stage 5 (CKD5) and identified a statistical relationship between PhA and age, which affects bone density.
Original paper ↗Read more →Appropriateness of drug prescriptions in patients with chronic kidney disease in primary care: a double-center retrospective study
The primary objective was to analyse the drug prescriptions of patients with CKD from two primary care centres to see if they were optimally adapted to the patient’s estimated glomerular filtration rate (eGFR).
Original paper ↗Read more →Dietary phosphorus source reprograms the kidney-intestine axis to dictate calcium-phosphorus efficiency and egg production in aging hens
The decline in egg production in aging hens poses a significant challenge to sustainable poultry production.
Original paper ↗Read more →L-shaped association of serum 25-hydroxyvitamin D with all-cause and cardiovascular mortality in older people with chronic kidney disease: results from the NHANES database prospective cohort study
We identified 3230 CKD participants aged ≥ 60 years from the National Health and Nutrition Examination Survey (2001 to 2018).
Original paper ↗Read more →Prognostic implications of serum ferritin levels in non-anemic women with stage 3 chronic kidney disease
Chronic kidney disease (CKD) is often accompanied by iron deficiency and persistent inflammation, both of which complicate the evaluation of iron metabolism and its clinical relevance.
Original paper ↗Read more →Relationship between Stage of Chronic Kidney Disease and Sarcopenia in Korean Aged 40 Years and Older Using the Korea National Health and Nutrition Examination Surveys (KNHANES IV-2, 3, and V-1, 2), 2008 to 2011
However, few studies have examined the relationship between early stages of chronic kidney disease (CKD) and sarcopenia.
Original paper ↗Read more →Original sources
Aging Decreases the Capacity of Human Skin to Produce Vitamin D3
Published in MacLaughlin J, Holick MF. Journal of Clinical Investigation (1985).
Publication details
Aging Decreases the Capacity of Human Skin to Produce Vitamin D3. MacLaughlin J, Holick MF. Journal of Clinical Investigation. 1985;76(4):1536 to 1538. DOI: 10.1172/JCI112134.
Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis.
Published in Tsai KS, Heath H III, Kumar R, Riggs BL. Journal of Clinical Investigation (1984).
Publication details
Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis. Tsai KS, Heath H III, Kumar R, Riggs BL. Journal of Clinical Investigation. 1984;73(6):1668 to 1672. DOI: 10.1172/JCI111373.
Comparative Study of Healthy Older and Younger Adults Shows They Have the Same Skin Concentration of Vitamin D3 Precursor, 7-Dehydrocholesterol, and Similar Response to UVR
Vitamin D3 synthesis in human skin is initiated by solar ultraviolet radiation (UVR) exposure of precursor 7-dehydrocholesterol (7DHC), but influence of age on the early stage of vitamin D3 metabolism is uncertain.
Publication details
Comparative Study of Healthy Older and Younger Adults Shows They Have the Same Skin Concentration of Vitamin D3 Precursor, 7-Dehydrocholesterol, and Similar Response to UVR. Borecka O et al. Nutrients. 2024;16(8):1147. The title does not establish statistical equivalence. DOI: 10.3390/nu16081147.
Alteration in vitamin D catabolic enzyme 24-hydroxylase in aging renal tubules affect tubular transport function
Alteration in vitamin D catabolic enzyme 24-hydroxylase in aging renal tubules affect tubular transport function.
Publication details
Alteration in vitamin D catabolic enzyme 24-hydroxylase in aging renal tubules affect tubular transport function. Zhang Z et al. Scientific Reports. Published 18 August 2026. Accepted, unedited article in press; not treated here as a final version of record. DOI: 10.1038/s41598-026-66249-y.
Production and Metabolic Clearance of 1,25-Dihydroxyvitamin D in Men: Effect of Advancing Age
Published in Halloran BP et al. Journal of Clinical Endocrinology and Metabolism (1990).
Publication details
Production and Metabolic Clearance of 1,25-Dihydroxyvitamin D in Men: Effect of Advancing Age. Halloran BP et al. Journal of Clinical Endocrinology and Metabolism. 1990;70(2):318 to 323. ABSTRACT ONLY: full principal unavailable; not counted as fully assessed evidence. DOI: 10.1210/jcem-70-2-318.
Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: evidence of an age-related intestinal resistance to 1,25-dihydroxyvitamin D action
Published in Eastell R et al. Journal of Bone and Mineral Research (1991).
Publication details
Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: evidence of an age-related intestinal resistance to 1,25-dihydroxyvitamin D action. Eastell R et al. Journal of Bone and Mineral Research. 1991;6(2):125 to 132. ABSTRACT ONLY: full principal unavailable; not counted as fully assessed evidence. DOI: 10.1002/jbmr.5650060205.